Morgan Stanley has adjusted its price target for Axon Enterprise (AXON), following a noticeable fall in the stock price. The decline, some suggest, is tied to heightened valuation risks and tariff woes, which led to a recent profit miss. Meanwhile, other market observers, such as The Motley Fool have sought insights via an interview with Axon President Josh Isner.
Despite a marked slide from its all-time high, many investors see this as an opportune moment to purchase Axon's stock in the form of options or direct acquisition. TD Cowen judges Axon as a good buy following this pullback and in view of the company’s promising scale prospects. This narrative, centered on a balance of risk and opportunity, reflects the evolving nature of Axon’s view in the market.
An aggressive acquisition strategy, strong public-safety growth narrative, recurring revenue growth, and AI expansion potential are driving positive sentiment despite an earnings miss. Analysts predict Axon shares could reach $900 by 2026. Yet, the stock witnessed another sharp fall due to the tariff impact. The stock is seeing a trend of heavy investor attention, with RBC Capital initiating coverage with an ‘Outperform’ recommendation.
Axon Enterprise AXON News Analytics from Mon, 14 Jul 2025 07:00:00 GMT to Fri, 02 Jan 2026 12:51:03 GMT - Rating 5 - Innovation 8 - Information 7 - Rumor 2
